Table 2.
Correlation between claudin expression and clinicopathological parameters of the triple-negative breast cancer patients
| Clinicopathological parameters | Number of patients | P | |
|---|---|---|---|
|
| |||
| Low expression (n=16; 20%), n (%) | High expression (n=65; 80%), n (%) | ||
| Age (years) | |||
| ≤55 | 9 (56) | 44 (68) | 0.38 |
| >55 | 7 (44) | 21 (32) | |
| Tumor size | |||
| T1 | 6 (37) | 19 (29) | 0.52 |
| T2-T4 | 10 (63) | 46 (71) | |
| Nodal status | |||
| N0 | 4 (25) | 14 (24) | 0.91 |
| N1-N2 | 12 (75) | 45 (76) | |
| Grade | |||
| I-II | 6 (37) | 20 (61) | 0.60 |
| III | 10 (63) | 45 (69) | |
| Stage | |||
| I-II | 12 (75) | 48 (74) | 0.92 |
| III-IV | 4 (25) | 17 (26) | |
| Ki-67 (%) | |||
| ≤30 | 9 (56) | 26 (40) | 0.24 |
| >30 | 7 (44) | 39 (60) | |
| Metastasis | |||
| Yes | 3 (19) | 5 (8) | 0.19 |
| No | 13 (81) | 60 (92) | |